SCHEMBL20619600

SCHEMBL20619600

Cc1cnc(N2CC3(CCOCC3)C2)c(C(=O)Nc2ccc(C=O)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN10A Q9Y5Y9 5/20 0.42
▸ ALDH1A1 P00352 4/20 0.38
▸ MAPT P10636 4/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ PKM P14618 2/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ ITGA4 P13612 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ MITF O75030 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ G6PD P11413 1/20 0.38
▸ MC4R P32245 1/20 0.38
▸ OPRK1 P41145 1/20 0.38
▸ CCR6 P51684 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24187976 0.88 LMNA (0.43) SCN10AALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL20598038 0.87 SCN10A (0.42) SCN10AALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL20619615 0.87 SCN10A (0.37) SCN10AALDH1A1MAPTLMNAPDE4B
SCHEMBL20619496 0.86 SCN10A (0.42) SCN10AALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL24187946 0.86 BACE1 (0.37) SCN10AALDH1A1MAPTPDE4B
SCHEMBL20597986 0.86 MAPK1 (0.42) SCN10AALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL20619910 0.84 MAPT (0.41) SCN10AALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL20620052 0.83 ALDH1A1 (0.48) ALDH1A1MAPTRAB9AL3MBTL1
SCHEMBL20619918 0.82 SCN10A (0.41) SCN10AALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL20619503 0.82 HCK (0.38) ALDH1A1MAPTRAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022010882-A1 DIHYDROQUINOXALINE AND DIHYDROPYRIDOPYRAZINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC, (US) 2022-01-13 — — WO disclosed
WO-2019199908-A1 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-10-17 — — WO disclosed
WO-2019006295-A1 HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-01-03 — — WO disclosed
Send feedback